Array
(
[id] => 1704
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1704.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => In cases of very high risk for VTE#, we suggest associating intra- or postoperative IPC with pharmacological prophylaxis.（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 在静脉血栓栓塞症极高风险的情况下，我们建议将术中或术后的间歇性充气加压装置与药物性预防措施联合使用。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在静脉血栓栓塞症极高风险的情况下，我们建议将术中或术后的间歇性充气加压装置与药物性预防措施联合使用。（证据分级：中或低；推荐强度：强推荐）
In cases of very high risk for VTE#, we suggest associating intra- or postoperative IPC with pharmacological prophylaxis.（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1705
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1705.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend against the use of graduated compression stockings for perioperative thromboprophylaxis, regardless of the risk for VTE.（Evidence level:High；Recommendation grade:weak）
[laiyuan] => 我们不建议将梯度压力袜用于围手术期的血栓预防，无论静脉血栓栓塞症的风险高低如何。我们建议下腔静脉滤器不应被用于原发性静脉血栓栓塞症的预防。（证据分级：高；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们不建议将梯度压力袜用于围手术期的血栓预防，无论静脉血栓栓塞症的风险高低如何。我们建议下腔静脉滤器不应被用于原发性静脉血栓栓塞症的预防。（证据分级：高；推荐强度：弱推荐）
We recommend against the use of graduated compression stockings for perioperative thromboprophylaxis, regardless of the risk for VTE.（Evidence level:High；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1706
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1706.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that an IVC filter should not be used for primary VTE prevention.（Evidence level:moderate/Low；Recommendation grade:weak）
[laiyuan] => 我们建议下腔静脉滤器不应被用于原发性静脉血栓栓塞症的预防。（证据分级：中或低；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议下腔静脉滤器不应被用于原发性静脉血栓栓塞症的预防。（证据分级：中或低；推荐强度：弱推荐）
We suggest that an IVC filter should not be used for primary VTE prevention.（Evidence level:moderate/Low；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1707
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1707.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest discussing the placement of a retrievable IVC filter preoperatively for highbleeding-risk surgical procedures that must be performed less than one month after a pulmonary embolism and/or proximal deep vein thrombosis of the lower limbs.（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 对于在下肢发生肺栓塞和/或近端深静脉血栓形成后不到一个月就必须进行的高出血风险外科手术，我们建议术前讨论下腔静脉滤器的置入问题。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于在下肢发生肺栓塞和/或近端深静脉血栓形成后不到一个月就必须进行的高出血风险外科手术，我们建议术前讨论下腔静脉滤器的置入问题。（证据分级：中或低；推荐强度：强推荐）
We suggest discussing the placement of a retrievable IVC filter preoperatively for highbleeding-risk surgical procedures that must be performed less than one month after a pulmonary embolism and/or proximal deep vein thrombosis of the lower limbs.（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1708
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1708.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend scheduling the removal of the IVC filter as soon as therapeutic-dose anticoagulation is resumed without complication. （Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 我们建议，一旦恢复无并发症的治疗剂量抗凝治疗，就应尽快安排取出下腔静脉滤器。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议，一旦恢复无并发症的治疗剂量抗凝治疗，就应尽快安排取出下腔静脉滤器。（证据分级：高；推荐强度：强推荐）
We recommend scheduling the removal of the IVC filter as soon as therapeutic-dose anticoagulation is resumed without complication. （Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1709
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1709.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend adjusting pharmacological thromboprophylaxis to renal function .（Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 我们建议根据肾功能调整药物性血栓预防措施。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议根据肾功能调整药物性血栓预防措施。（证据分级：高；推荐强度：强推荐）
We recommend adjusting pharmacological thromboprophylaxis to renal function .（Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1710
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1710.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with severe renal impairment, we suggest LMWH over UFH or DOAC.（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 对于重度肾功能损害的患者，我们建议优先使用低分子量肝素，而非普通肝素或直接口服抗凝剂。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于重度肾功能损害的患者，我们建议优先使用低分子量肝素，而非普通肝素或直接口服抗凝剂。（证据分级：中或低；推荐强度：强推荐）
In patients with severe renal impairment, we suggest LMWH over UFH or DOAC.（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1711
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1711.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend using the following LMWH according to the dosing regimens indicated by the marketing authorization:enoxaparin 2000 IU x 1/day SC if eGFR is between 15 and 30 mL/min/1.73 m²tinzaparin 4500 IU x 1/day SC if eGFR is > 20 mL/min/1.73 m²（Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 我们建议按照上市许可所标明的给药方案使用以下低分子量肝素：如果估算的肾小球滤过率在15至30 mL/min/1.73 m²之间，依诺肝素皮下注射，每日一次，每次2000IU；如果肾小球滤过率大于20 mL/min/1.73 m²，亭扎肝素皮下注射，每日一次，每次4500IU。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议按照上市许可所标明的给药方案使用以下低分子量肝素：如果估算的肾小球滤过率在15至30 mL/min/1.73 m²之间，依诺肝素皮下注射，每日一次，每次2000IU；如果肾小球滤过率大于20 mL/min/1.73 m²，亭扎肝素皮下注射，每日一次，每次4500IU。（证据分级：高；推荐强度：强推荐）
We recommend using the following LMWH according to the dosing regimens indicated by the marketing authorization:enoxaparin 2000 IU x 1/day SC if eGFR is between 15 and 30 mL/min/1.73 m²tinzaparin 4500 IU x 1/day SC if eGFR is > 20 mL/min/1.73 m²（Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1712
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1712.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => For patients with end-stage renal disease, we recommend using UFH at a dose of 5000 IU x 2/day SC, as other anticoagulants are not recommended.（Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 对于终末期肾病患者，我们建议使用普通肝素，皮下注射，每日两次，每次5000IU，因为其他抗凝剂不建议使用。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于终末期肾病患者，我们建议使用普通肝素，皮下注射，每日两次，每次5000IU，因为其他抗凝剂不建议使用。（证据分级：高；推荐强度：强推荐）
For patients with end-stage renal disease, we recommend using UFH at a dose of 5000 IU x 2/day SC, as other anticoagulants are not recommended.（Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1713
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1713.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => For patients with class I or II obesity (BMI between 30 and 39 kg/m²) requiring pharmacological thromboprophylaxis, we suggest using a standard dosing regimen .（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 对于需要进行药物性血栓预防的I级或II级肥胖（体重指数在30至39kg/m²之间）的患者，我们建议采用标准给药方案。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于需要进行药物性血栓预防的I级或II级肥胖（体重指数在30至39kg/m²之间）的患者，我们建议采用标准给药方案。（证据分级：中或低；推荐强度：强推荐）
For patients with class I or II obesity (BMI between 30 and 39 kg/m²) requiring pharmacological thromboprophylaxis, we suggest using a standard dosing regimen .（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
